These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 23383610)

  • 21. Integrated analysis of multiple microarray datasets identifies a reproducible survival predictor in ovarian cancer.
    Konstantinopoulos PA; Cannistra SA; Fountzilas H; Culhane A; Pillay K; Rueda B; Cramer D; Seiden M; Birrer M; Coukos G; Zhang L; Quackenbush J; Spentzos D
    PLoS One; 2011 Mar; 6(3):e18202. PubMed ID: 21479231
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of Skt11-regulated genes in chondrocytes by integrated bioinformatics analysis.
    Liang S; Zhang JM; Lv ZT; Cheng P; Zhu WT; Chen AM
    Gene; 2018 Nov; 677():340-348. PubMed ID: 30107230
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Four genes relevant to pathological grade and prognosis in ovarian cancer.
    Pan X; Chen Y; Gao S
    Cancer Biomark; 2020; 29(2):169-178. PubMed ID: 32444534
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Prognostic 97 Chemoresponse Gene Signature in Ovarian Cancer.
    Matondo A; Jo YH; Shahid M; Choi TG; Nguyen MN; Nguyen NNY; Akter S; Kang I; Ha J; Maeng CH; Kim SY; Lee JS; Kim J; Kim SS
    Sci Rep; 2017 Aug; 7(1):9689. PubMed ID: 28851888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of MEG8/miR-378d/SOBP axis as a novel regulatory network and associated with immune infiltrates in ovarian carcinoma by integrated bioinformatics analysis.
    Lei J; He ZY; Wang J; Hu M; Zhou P; Lian CL; Hua L; Wu SG; Zhou J
    Cancer Med; 2021 Apr; 10(8):2924-2939. PubMed ID: 33742531
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathway-based identification of a smoking associated 6-gene signature predictive of lung cancer risk and survival.
    Guo NL; Wan YW
    Artif Intell Med; 2012 Jun; 55(2):97-105. PubMed ID: 22326768
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lysine demethylase 2A promotes the progression of ovarian cancer by regulating the PI3K pathway and reversing epithelial‑mesenchymal transition.
    Lu DH; Yang J; Gao LK; Min J; Tang JM; Hu M; Li Y; Li ST; Chen J; Hong L
    Oncol Rep; 2019 Feb; 41(2):917-927. PubMed ID: 30483796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ICan: an integrated co-alteration network to identify ovarian cancer-related genes.
    Zhou Y; Liu Y; Li K; Zhang R; Qiu F; Zhao N; Xu Y
    PLoS One; 2015; 10(3):e0116095. PubMed ID: 25803614
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HOTAIR promotes paclitaxel resistance by regulating CHEK1 in ovarian cancer.
    Jiang J; Wang S; Wang Z; Cai J; Han L; Xie L; Han Q; Wang W; Zhang Y; He X; Yang C
    Cancer Chemother Pharmacol; 2020 Aug; 86(2):295-305. PubMed ID: 32743678
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of Key Genes and Pathway for Ovarian Neoplasms Using the OVDM1 Cell Line Based on Bioinformatics Analysis.
    Yin S; Du J; Zhang J; Zhang X; Ma K
    Med Sci Monit; 2019 Jun; 25():4305-4313. PubMed ID: 31177266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systematic prediction of key genes for ovarian cancer by co-expression network analysis.
    Wang M; Wang J; Liu J; Zhu L; Ma H; Zou J; Wu W; Wang K
    J Cell Mol Med; 2020 Jun; 24(11):6298-6307. PubMed ID: 32319226
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A prognostic 11 genes expression model for ovarian cancer.
    Men CD; Liu QN; Ren Q
    J Cell Biochem; 2018 Feb; 119(2):1971-1978. PubMed ID: 28817186
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Three-microRNA signature identified by bioinformatics analysis predicts prognosis of gastric cancer patients.
    Zhang C; Zhang CD; Ma MH; Dai DQ
    World J Gastroenterol; 2018 Mar; 24(11):1206-1215. PubMed ID: 29568201
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In silico analyses identify gene-sets, associated with clinical outcome in ovarian cancer: role of mitotic kinases.
    Ocaña A; Pérez-Peña J; Alcaraz-Sanabria A; Sánchez-Corrales V; Nieto-Jiménez C; Templeton AJ; Seruga B; Pandiella A; Amir E
    Oncotarget; 2016 Apr; 7(16):22865-72. PubMed ID: 26992217
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prediction of candidate RNA signatures for recurrent ovarian cancer prognosis by the construction of an integrated competing endogenous RNA network.
    Wang X; Han L; Zhou L; Wang L; Zhang LM
    Oncol Rep; 2018 Nov; 40(5):2659-2673. PubMed ID: 30226545
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ChIP-seq defined genome-wide map of TGFβ/SMAD4 targets: implications with clinical outcome of ovarian cancer.
    Kennedy BA; Deatherage DE; Gu F; Tang B; Chan MW; Nephew KP; Huang TH; Jin VX
    PLoS One; 2011; 6(7):e22606. PubMed ID: 21799915
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Linking the ovarian cancer transcriptome and immunome.
    Rapberger R; Perco P; Sax C; Pangerl T; Siehs C; Pils D; Bernthaler A; Lukas A; Mayer B; Krainer M
    BMC Syst Biol; 2008 Jan; 2():2. PubMed ID: 18173842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential co-expression analysis reveals a novel prognostic gene module in ovarian cancer.
    Gov E; Arga KY
    Sci Rep; 2017 Jul; 7(1):4996. PubMed ID: 28694494
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An integrated network of microRNA and gene expression in ovarian cancer.
    Quitadamo A; Tian L; Hall B; Shi X
    BMC Bioinformatics; 2015; 16 Suppl 5(Suppl 5):S5. PubMed ID: 25860109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene expression profiling of ovarian carcinomas and prognostic analysis of outcome.
    Cai SY; Yang T; Chen Y; Wang JW; Li L; Xu MJ
    J Ovarian Res; 2015 Jul; 8():50. PubMed ID: 26228058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.